VACCINE AWARENESS - ADULT VACCINATION - WHY VACCINATE - ADULT IMMUNIZATIONS

For Media
While the childhood immunization program has been largely successful in controlling vaccine-preventable diseases in the U.S., this same widespread success has not been achieved with adult vaccinations. Adult vaccination rates remain low, and this lack of protection results in the deaths of about 50,000 American adults each year and thousands more hospitalizations.

Adults prioritize pediatric immunizations for their children and grandchildren; however, they often fail to protect themselves. To reverse this trend, better education is needed about the impact of adult diseases and the benefits of vaccination.

As intermediaries for consumers seeking information on health-related issues, media can play a critical role in educating the public about the importance of adult vaccination. This section of AdultVaccination.com provides accurate, up-to-date information that will assist you in reporting on adult vaccine-preventable diseases.

Members of the media who require further assistance may email their inquiry to . Please be sure to include your name, media outlet, topic and deadline in your message.


Press Releases
Young Adults Unaware of Threat of Infectious Disease and the Availability of Preventive Vaccines: Experts Call for Increased Awareness and Vaccination Rates among All Adults
July 22, 2009

NFID Calls for Increased Immunization Rates among Adults; Launches Comprehensive Web site to Educate Public, Healthcare Providers
April 3, 2009


Events
Nations’s Top Medical Experts Urges Vaccination for More Adults (News Conference)
July 22, 2009

U.S. Adult Immunization Program: A Checkup (An Online Scientific Symposium)
April 2, 2009

 

Nation’s Top Medical Experts Urge Vaccination for More Adults

July 22, 2009



Contact:
Jennifer Corrigan
jenn.corrigan@comcast.net
Office: 732-382-8898
Mobile: 732-742-7148
 
Contact Us  |  About NFID  |  Adult Immunization Report  |  Supporting Organizations This Web site is supported by unrestricted educational grants to the National Foundation for Infectious Diseases from GlaxoSmithKline, Merck & Co., Inc., sanofi pasteur and Wyeth Pharmaceuticals.